Influence of glucose concentration on the inhibitory effect of amylin on insulin secretion. Study in the perfused rat pancreas

Regulatory Peptides

Volumn 68, Issue 1, 1997, Pages 31-35

  Silvestre, R A ^a   Rodriguez Gallardo J ^a   Gutierrez E ^a   Marco, J ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Amylin; Insulin secretion; Islet amyloid polypeptide; Rat pancreas

Indexed keywords

AMYLIN; GLUCOSE; INSULIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; IN VITRO STUDY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS SECRETION; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031568246     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(96)00139-5     Document Type: Article

References (29)

1. Lukinius, A., Wilander, E., Westermark, G.T., Engstron, U. and Westermark, P., Co-localization of islet amyloid polypeptide and insulin in the B-cell secretory granules of the human pancreatic islets. Diabetologia, 32 (1989) 240-244.
2. Clark, A., Edwards, C.A., Ostle, L.R., Sutton, R., Rothbard, J.B., Morris, J.F. and Turner, R.C., Localization of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type 2 diabetic subjects. Cell. Tis. Res., 257 (1989) 179-185.
3. Johnson, K.H., O'Brien, T.D. and Westermark, P., Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes? Diabetes, 40 (1991) 310-314.
4. Gaeta, L.S.L. and Rink, T.J., Amylin: a new hormone as a therapeutic target in diabetes mellitus and other metabolic diseases. Med. Chem. Res., 3 (1994) 483-490.
5. Castillo, M.J., Scheen, A.J. and Lefèbvre, P.J., Amylin/Islet amyloid polypeptide: Biochemistry, Physiology, Patho-Physiology. Diabete. Metab., 21 (1995) 3-25.
6. Fehmann, H.C., Weber, V., Göke, R., Göke, B., Eissele, R. and Arnold, R., Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas. Biochem. Biophys. Res. Commun., 167 (1990) 1102-1108.
7. Nagamatsu, S., Carroll, R.J., Grodsky, G.M. and Steiner, D.F., Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets. Diabetes, 39 (1990) 871-874.
8. Silvestre, R.A., Peiró, E., Dégano, P., Miralles, P. and Marco, J., Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul. Pept., 31 (1990) 23-31.
9. Dégano, P., Silvestre, R.A., Salas, M., Peiró, E. and Marco, J., Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul. Pept., 43 (1993) 91-96.
10. Silvestre, R.A., Salas, M., Dégano, P., Peiró, E. and Marco, J., Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP. Biochem. Pharmacol., 45 (1993) 2343-2347.
11. Rodríguez-Gallardo, J., Silvestre, R.A., Salas, M. and Marco, J., Rat amylin versus human amylin: Effects on insulin secretion in the perfused rat pancreas. Med. Sci. Res., 23 (1995) 569-570.
12. Leclercq-Meyer, V., Marchand, J., Leclercq, R. and Malaisse, W.J., Glucagon and insulin release by the in vitro perfused rat pancreas. Diabete. Metab., 2 (1976) 57-65.
13. Silvestre, R.A., Miralles, P., Moreno, P., Villanueva, M.L. and Marco, J., Somatostatin, insulin and glucagon secretion by the perfused rat pancreas from the cysteamine-treated rats. Biochem. Biophys. Res. Commun., 134 (1986) 1291-1297.
14. Krebs, H.A. and Henseleit, K., Untersuchungen über die Harnstoff-bildung im Tierköper. Hoppe-Seyler's Z. Physiol. Chem., 210 (1932) 33-66.
15. Yalow, R.S. and Bergson, S.A., Immunoassay of endogenous plasma insulin in man. J. Clin. Invest., 39 (1960) 1157-1175.
16. Herbert, V., Lau, K.S., Gottlieb, C.W. and Bleicher, S.J., Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab., 25 (1965) 1375-1384.
17. Siegel, S., Non parametric statistic for the behavioral changes. McGraw-Hill, New York, 1978.
18. Peiró, E., Dégano, P., Silvestre, R.A. and Marco, J., Inhibition of insulin release by amylin is not mediated by change in somatostatin output. Life Sci., 49 (1991) 761-765.
19. Silvestre, R.A., Salas, M., García-Hermida, O., Fontela, T., Dégano, P. and Marco, J., Amylin inhibition of insulin release in the perfused rat pancreas: Implication of the adenylate cyclase/cAMP system. Regul. Pept., 50 (1994) 193-199.
20. Salas, M., Silvestre, R.A., García-Hermida, O., Fontela, T., Rodríguez-Gallardo, J. and Marco, J., Inhibitory effect of amylin (IAPP) on the insulin response to non-glucose stimuli. Study in the perfused rat pancreas. Diabete. Metab., 21 (1995) 269-273.
21. Marco, J., Hedo, J.A., Villanueva, M.L., Calle, C., Corujedo, A. and Segovia, J.M., Effect of food ingestion on intestinal glucagon-like immunoreactivity (GLI) secretion in normal and gastrectomized subjects. Diabetologia, 13 (1977) 131-135.
22. Pettersson, M. and Ahrén, B., Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats. Acta Physiol. Scand., 138 (1990) 389-394.
23. O'Brien, T.D., Westermark, P. and Johnson, K.H., Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas. Biochem. Biophys. Res. Commun., 170 (1990) 1223-1228.
24. Tedstone, A.E., Nezzer, T., Hughes, S.J., Clark, A. and Matthews, D.R., The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro. Biosci. Rep., 10 (1990) 339-345.
25. Broderick, C.L., Brooke, G.S., Dimarchi, R.D. and Gold, G., Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets. Biochem. Biophys. Res. Commun., 177 (1991) 932-938.
26. Pipeleers, D., The biosociology of pancreatic B cells. Diabetologia, 30 (1987) 277-291.
27. Beaumont, K., Moore, C.X., Pittner, R., Carlo, P., Young, A.A., Rink, T.J., Prickett, T. and Gaeta, S.L.S., Blockade of amylin actions in rat skeletal muscle and in vivo by amylin receptor antagonists. Can. J. Physiol. Pharm., 72 (1994) 225.
28. Silvestre, R.A., Salas, M., Rodríguez-Gallardo, J., García-Hermida, O., Fontela, T. and Marco, J., Effect of 8-32 salmon calcitonin, an amylin antagonist, on insulin, glucagon and somatostatin release. Study in the perfused rat pancreas. Br. J. Pharm., 117 (1996) 347-50.
29. Matthews, D.R., Lang, D.A., Burnett, M.A. and Turner, R.C., Control of pulsatile insulin secretion in men. Diabetologia, 24 (1983) 231-237.